AI Article Synopsis
- COVID-19 can lead to serious blood clotting problems, prompting the use of preventive anticoagulation for hospitalized patients.
- A 71-year-old woman with several health risks developed acute mesenteric ischemia and pulmonary embolism while receiving high-dose anticoagulation for COVID-19 pneumonia.
- This case highlights the urgency of recognizing such complications in COVID-19 patients and raises questions about the potential need for more aggressive anticoagulation treatment.
Article Abstract
COVID-19 infection is known to cause thromboembolic complications. This is why patients hospitalized with COVID-19 are put on prophylactic anticoagulation. We present the case of a Caucasian woman, aged 71 years, with risk factors of class 1 obesity, hyperlipidemia, and hypertension, initially admitted for COVID-19 pneumonia, and later developed acute mesenteric ischemia followed by pulmonary embolism. These incidents occurred while the patient was receiving high-dose prophylactic enoxaparin (40 mg twice daily). COVID-19 associated acute mesenteric ischemia is a complication with high mortality. Therefore, high suspicion, early recognition, and surgical management is necessary. Apart from that, this case emphasizes the question of whether there is a need for proactively administering therapeutic anticoagulation for high thrombotic risk COVID-19 patients to prevent deadly complications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799224 | PMC |
| http://dx.doi.org/10.3121/cmr.2022.1751 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!